Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Gilead SciencesGILD |
$73,000 |
 |
AmgenAMGN |
$99,000 |
 |
BridgeBio PharmaBBIO |
$16,000 |
 |
Alnylam PharmaceuticalsALNY |
-$41,000 |
 |
United TherapeuticsUTHR |
$8,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan | May 15, 2025 | Buy | $1K - $15K |
| Byron Donalds | Apr 10, 2025 | Sell | $1K - $15K |
| Rob Bresnahan | Feb 25, 2025 | Sell | $1K - $15K |
| Julie Johnson | Feb 12, 2025 | Sell | $1K - $15K |
| Josh Gottheimer | Jan 24, 2025 | Sell | $1K - $15K |
| Julie Johnson | Jan 15, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | Nov 29, 2024 | Sell | $1K - $15K |
| Josh Gottheimer | Nov 19, 2024 | Sell | $1K - $15K |
| Jonathan Jackson | Nov 13, 2024 | Sell | $15K - $50K |
| Jonathan Jackson | Nov 1, 2024 | Sell | $1K - $15K |
| Josh Gottheimer | Oct 23, 2024 | Sell | $1K - $15K |
| Greg Landsman | Oct 15, 2024 | Sell | $1K - $15K |
| Ro Khanna | Sep 9, 2024 | Buy | $1K - $15K |
| Thomas Tuberville Republican | Apr 4, 2024 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat | Feb 8, 2024 | Sell | $1K - $15K |
| Jonathan Jackson Democrat | Jan 17, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Jan 10, 2024 | Buy | $1K - $15K |
| Joshua Gottheimer Democrat | Nov 13, 2023 | Sell | $1K - $15K |
Who is the latest politician to buy or sell Regeneron shares?
Rob Bresnahan purchased Regeneron shares most recently on May 15, 2025.
Which politician has bought the most REGN stock in the last two years?
Rohit Khanna has bought the most REGN stock in the last 2 years, with an estimated value of $8,000.
Which politician has sold the most REGN stock over the last two years?
Jonathan Jackson has sold the most REGN stock in the last 2 years, with an estimated value of $41,000.
What is the total value of politicians trading REGN stock in the last 2 years?
The net value of trades by US politicians for Regeneron in the last 2 years is negative, amounting to -$89,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Regeneron's market confidence?
Over the last 2 years, insider transactions for Regeneron have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
